Synapse - Works

Results (4760)

Phase 1 study of CB-839, a small molecule inhibitor of glutaminase (GLS) in combination with paclitaxel (Pac) in patients (pts) with triple negative breast cancer (TNBC)

Meeting Abstract

DeMichele, A.; Harding, J. J.; Telli, M. L.; Munster, P. N.; McKay, R.; Iliopoulos, O.; Orford, K. W.; Bennett, M. K.; Mier, J. W.; Owonikoko, T. K.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A phase II study of the PI3K inhibitor taselisib (GDC-0032) combined with fulvestrant (F) in patients (pts) with HER2-negative (HER2-), hormone receptor positive (HR+) advanced breast cancer (BC)

Meeting Abstract

Dickler, M. N.; Saura, C.; Richards, D. A.; Krop, I. E.; Cervantes, A.; Bedard, P. L.; Patel, M. R.; Pusztai, L.; Oliveira, M.; Ware, J. A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Patient-reported outcomes from randomized, phase-3 study of trabectedin (T) vs. dacarbazine (D) in advanced Ieiomyosarcoma (LMS) or liposarcoma (LPS)

Meeting Abstract

Demetri, G. D.; von Mehren, M.; Jones, R. L.; Hensley, M. L.; Schuetze, S.; Elias, A. D.; Pierson, R. F.; Knoblauch, R. E.; Park, Y. C.; Wang, G. C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Obesity and breast cancer: Analysis of Breast Cancer Collaborative Registry (BCCR) data in a rural community cancer center

Meeting Abstract

Copur, M. S.; Bigley, S.; Frey, N.; Gonen, M.; Hadenfeldt, R.; Gulzow, M.; Einspahr, S.; Usasz, K.; Thomson, M.; Gnewuch, C.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Potential cost savings by dose rounding monoclonal antibodies (mAB) in a community cancer center

Meeting Abstract

Copur, M. S.; Gnewuch, C.; Schriner, M.; Gonen, M.; McDonald, M.; Kezeor, J.; Tharnish, M.; Ramaekers, R. C.; Gauchan, D.; Clark, D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A phase 1/2 study combining ipilimumab with abiraterone acetate plus prednisone in chemotherapy- and immunotherapy-naive patients with progressive metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Danila, D. C.; Kuzel, T.; Cetnar, J. P.; Rathkopf, D. E.; Morris, M. J.; Alumkal, J. J.; Butler, A.; Curley, T.; Hullings, M.; Buddle, J. R.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation between comprehensive molecular profiling and clinical outcomes in patients with colorectal liver metastases

Meeting Abstract

Connell, L. C.; Sanchez-Vega, F.; Boucher, T. M.; Yaeger, R. D.; Schultz, N.; Cercek, A.; Hechtman, J. F.; Kemeny, N. E.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

A randomized, phase 2 trial of denintuzumab mafodotin and RICE vs RICE alone in the treatment of patients (pts) with relapsed/refractory (r/r) diffuse large B-cell lymphoma (DLBCL) who are candidates for autologous stem cell transplant (ASCT)

Meeting Abstract

Chen, R. W.; Jacobsen, E. D.; Kostic, A.; Liu, T.; Moskowitz, C. H.
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Overall survival (OS) in METEOR, a randomized phase 3 trial of cabozantinib (Cabo) versus everolimus (Eve) in patients (pts) with advanced renal cell carcinoma (RCC)

Meeting Abstract

Choueiri, T. K.; Powles, T.; Escudier, B. J.; Tannir, N. M.; Mainwaring, P.; Rini, B. I.; Hammers, H. J.; Donskov, F.; Roth, B. J.; Peltola, K.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC)

Meeting Abstract

Coleman, R. L.; Swisher, E. M.; Oza, A. M.; Scott, C. L.; Giordano, H.; Lin, K. K.; Konecny, G. E.; Tinker, A.; O'Malley, D. M.; Kristeleit, R. S.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save